AMED * Stock Overview
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Amedisys, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$1,566.00 |
52 Week High | US$2,030.00 |
52 Week Low | US$1,469.00 |
Beta | 1.0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -68.20% |
5 Year Change | n/a |
Change since IPO | -30.71% |
Recent News & Updates
Recent updates
Shareholder Returns
AMED * | MX Healthcare | MX Market | |
---|---|---|---|
7D | 0% | 5.0% | 2.4% |
1Y | n/a | 5.0% | 2.7% |
Return vs Industry: Insufficient data to determine how AMED * performed against the MX Healthcare industry.
Return vs Market: Insufficient data to determine how AMED * performed against the MX Market.
Price Volatility
AMED * volatility | |
---|---|
AMED * Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 5.3% |
Market Average Movement | 3.8% |
10% most volatile stocks in MX Market | 6.1% |
10% least volatile stocks in MX Market | 1.9% |
Stable Share Price: AMED * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AMED *'s volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1982 | 20,000 | Richard Ashworth | www.amedisys.com |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through four segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Amedisys, Inc. Fundamentals Summary
AMED * fundamental statistics | |
---|---|
Market cap | Mex$53.39b |
Earnings (TTM) | Mex$40.55m |
Revenue (TTM) | Mex$38.80b |
1,317x
P/E Ratio1.4x
P/S RatioIs AMED * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AMED * income statement (TTM) | |
---|---|
Revenue | US$2.23b |
Cost of Revenue | US$1.76b |
Gross Profit | US$468.15m |
Other Expenses | US$465.82m |
Earnings | US$2.33m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.071 |
Gross Margin | 21.00% |
Net Profit Margin | 0.10% |
Debt/Equity Ratio | 35.6% |
How did AMED * perform over the long term?
See historical performance and comparison